Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aina He

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Theranostics|November 22, 2017
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated deliveryDongxi Xiang, Sarah Shigdar, Andrew G Bean, et al.
Life Science Alliance|October 21, 2022
Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKBAina He, Lanjing Ma, Yujing Huang, et al.
Life Science Alliance|April 3, 2020
CDKL3 promotes osteosarcoma progression by activating Akt/PKBAina He, Lanjing Ma, Yujing Huang, et al.
The Journal of Clinical Investigation|August 9, 2011
IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- miceJing Wang, Xiang Cheng, Mei-Xiang Xiang, et al.
The Journal of Clinical Investigation|November 2, 2018
IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- miceJing Wang, Xiang Cheng, Mei-Xiang Xiang, et al.
Plos Biology|November 9, 2023
Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growthAina He, Songhai Tian, Oded Kopper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2022
First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001Yan Zhou, Qingcheng Yang, Yang Dong, et al.
Nature Communications|May 1, 2021
Author Correction: Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcomaYan Zhou, Dong Yang, Qingcheng Yang, et al.
Nature Communications|December 11, 2020
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcomaYan Zhou, Dong Yang, Qingcheng Yang, et al.
Cell Proliferation|April 24, 2026
Human Pancreatic Cancer OrganoidsAina He, Xiaolin Lin, Xiaozhe Qian, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Theranostics|November 22, 2017
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated deliveryDongxi Xiang, Sarah Shigdar, Andrew G Bean, et al.
Life Science Alliance|October 21, 2022
Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKBAina He, Lanjing Ma, Yujing Huang, et al.
Life Science Alliance|April 3, 2020
CDKL3 promotes osteosarcoma progression by activating Akt/PKBAina He, Lanjing Ma, Yujing Huang, et al.
The Journal of Clinical Investigation|August 9, 2011
IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- miceJing Wang, Xiang Cheng, Mei-Xiang Xiang, et al.
The Journal of Clinical Investigation|November 2, 2018
IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- miceJing Wang, Xiang Cheng, Mei-Xiang Xiang, et al.
Plos Biology|November 9, 2023
Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growthAina He, Songhai Tian, Oded Kopper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2022
First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001Yan Zhou, Qingcheng Yang, Yang Dong, et al.
Nature Communications|May 1, 2021
Author Correction: Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcomaYan Zhou, Dong Yang, Qingcheng Yang, et al.
Nature Communications|December 11, 2020
Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcomaYan Zhou, Dong Yang, Qingcheng Yang, et al.
Cell Proliferation|April 24, 2026
Human Pancreatic Cancer OrganoidsAina He, Xiaolin Lin, Xiaozhe Qian, et al.
Pageof 6